Copyright 2013 Narconon UK
Narconon and the Narconon logo are trademarks and service marks owned by the Association for Better Living and Education International and are used with its permission.
FAQ About Ecstasy
MDMA (3-4 methylenedioxymethamphetamine) is a synthetic, psychoactive drug chemically similar to the stimulant methamphetamine and the hallucinogen mescaline. Street names for MDMA include Ecstasy, Adam, XTC, hug, beans, and love drug. In 2002, an estimated 676,000 people in the U.S. age 12 and older used MDMA.*
Research in animals indicates that MDMA is neurotoxic; whether or not this is also true in humans is currently an area of intense investigation. MDMA can also be dangerous to health and, on rare occasions, lethal.
MDMA exerts its primary effects in the brain on neurons that use the chemical serotonin to communicate with other neurons. The serotonin system plays an important role in regulating mood, aggression, sexual activity, sleep, and sensitivity to pain.
Health Hazards from Ecstasy
Because MDMA can interfere with its own metabolism (breakdown within the body), potentially harmful levels can be reached by repeated drug use within short intervals.
Users of MDMA face many of the same risks as users of other stimulants such as cocaine and amphetamines. These include increases in heart rate and blood pressure, a special risk for people with circulatory problems or heart disease, and other symptoms such as muscle tension, involuntary teeth clenching, nausea, blurred vision, faintness, and chills or sweating.
Research in animals links MDMA exposure to long-term damage to neurons that are involved in mood, thinking, and judgment. A study in nonhuman primates showed that exposure to MDMA for only 4 days caused damage to serotonin nerve terminals that was evident 6 to 7 years later. While similar neurotoxicity has not been definitively shown in humans, the wealth of animal research indicating MDMA's damaging properties suggests that MDMA is not a safe drug for human consumption.
Hidden Risk: Drug Purity
Other drugs chemically similar to MDMA, such as MDA (methylenedioxyamphetamine, the parent drug of MDMA) and PMA (paramethoxyamphetamine, associated with fatalities in the U.S. and Australia) are sometimes sold as ecstasy. These drugs can be neurotoxic or create additional health risks to the user. Also, ecstasy tablets may contain other substances in addition to MDMA, such as ephedrine (a stimulant); dextromethorphan (DXM, a cough suppressant that has PCP-like effects at high doses); ketamine (an anaesthetic used mostly by veterinarians that also has PCP-like effects); caffeine; cocaine; and methamphetamine. While the combination of MDMA with one or more of these drugs may be inherently dangerous, users might also combine them with substances such as marijuana and alcohol, putting themselves at further physical risk.
Extent of Use
Community Epidemiology Work Group (CEWG)**
CEWG members monitor drug use data sources for 21 metropolitan areas nationwide. In many of these areas monitored by CEWG members, MDMA, once used primarily at dance clubs, raves, and college scenes, is being used in a number of other social settings.
The number of MDMA emergency department (ED) mentions decreased in 11 CEWG areas from the first and/or second half of 2001 to the first half of 2002, with a significant increase reported only in New Orleans. The highest numbers of MDMA ED mentions in the 2002 period were in Philadelphia, Miami, San Francisco, Atlanta, Los Angeles, and New York.
It's all about results!
What Causes Drug Addiction and Alcoholism?
Download: The Cycle of Addiction (PDF)
or email us
for free advice:
"...the best high is the adrenalin rush
of completing the Narconon programme"
Read the whole story
"Your efforts are most likely the reason our son developed the will to change ..."
"I wake up every morning looking forward to my day ahead because I know I'm in total control of my life and because I rediscovered myself ..."
"...I was very sceptic at first but now I feel Narconon is the only way - it's working for me."
"After seeing the results of your work and speaking to members of the staff, I feel that you have much to teach the drug rehabilitation field"
"I came to NARCONON a broken mess of a human being. ... Today I have no words to really explain the difference in my life. ... I am successful and happy and I have a future."